Evidence map›Paper›PMID 32123636›Full record

ArticleInternational journal of MCH and AIDS2020

House Ball Community Leaders' Perceptions of HIV and HIV Vaccine Research.

Amina P Alio, Candace Sibley, Halimah S Ouedraogo, Stephaun E Wallace, Steven Wakefield, Damon L Humes, Sheldon D Fields, Michael C Keefer

Open access · goldAbstract read
In one paragraph

Article in International journal of MCH and AIDS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Amina P AlioUniversity of Rochester School of Medicine and Dentistry, Department of Public Health Sciences, Division of Social and Behavioral Sciences, 265 Crittenden Blvd, Rochester NY, 14642, USA.
Candace SibleyICF International, 3 Corporate Blvd NE #370, Atlanta, GA 30329, USA.
Halimah S OuedraogoUniversity of Rochester School of Medicine and Dentistry, Department of Public Health Sciences, Division of Social and Behavioral Sciences, 265 Crittenden Blvd, Rochester NY, 14642, USA.
Stephaun E WallaceFred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
Steven WakefieldFred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
Damon L HumesFred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
Sheldon D FieldsNew York Institute of Technology, School of Health Professions, Riland Academic Health Center, Room 347, Old Westbury, NY, 11568, USA.
Michael C KeeferUniversity of Rochester School of Medicine and Dentistry, Department of Public Health Sciences, Division of Social and Behavioral Sciences, 265 Crittenden Blvd, Rochester NY, 14642, USA.
Fred Hutch Cancer Center · USUniversity of Rochester · USICF International (United States) · USNew York Institute of Technology · US

Funding

University of Rochester HIV/AIDS Clinical Trials Unit Administrative SupplementUM1AI069511 · NIAID · UNIVERSITY OF ROCHESTER · PI Paul R Bohjanen, MICHAEL C KEEFER · 2012 to 2026
$25.7M
Virology/Immunology CoreP30AI078498 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2018
$14.6M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
Minority Populations Prevention Researcher TrainingR25HD045810 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NEILANDS, TORSTEN BRIAN · 2003 to 2018
$4.3M
The University of Rochester Clinical and Translational Science InstituteTL1TR000096 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$930k
NCATS NIH HHS TL1 TR000096NIAID NIH HHS P30 AI078498NIAID NIH HHS UM1 AI069511NICHD NIH HHS R25 HD045810NIMH NIH HHS R25 MH067127
6 · The paper itself

Abstract

BACKGROUND OR

objectivesWorldwide, men who have sex with men (MSM) and Transgender persons are vulnerable to psychosocial factors associated with high risk for HIV, and suffer disproportionately high rates of HIV/AIDS. In the United States (US), the House Ball Community (HBC) is a social network comprised predominantly of Black and Hispanic MSM and Transgender persons who reside in communal settings. This study explores Western New York HBC leaders' perceptions of HIV in their communities and their knowledge of HIV prevention strategies, including HIV vaccine trials.

methodsThe project was conducted using an exploratory approach based on the principles of Community-Based Participatory Research (CBPR) methods. An HIV behavioral risk assessment provided descriptive data, while qualitative measures explored psychosocial and behavioral factors.

resultsBehavioral assessments indicated high levels of risky sexual behaviors and experiences of violence. Interviews with 14 HBC leaders revealed that knowledge of HIV and local HIV vaccines trials was limited. Barriers to HIV knowledge included fear of peer judgment, having inaccurate information, and lack of formal education. Experiencing violence was identified as barrier to positive health behavior. Nevertheless, the HBC was described as a safe and creative space for marginalized MSM and Transgender youth. CONCLUSION AND GLOBAL HEALTH IMPLICATIONS: Findings suggest that the interrelation between health problems and social context amplify HIV risk in the HBC. The organizational structure and resources of the HBC, and MSM/Transgender communities worldwide can be instrumental in informing interventions to address HIV-related risk behaviors and create appropriate recruitment tools to ensure their representation in HIV research.

Indexed as

HIVHIV and black/Latino MSMHIV risk factorsLGBTMSMMSM/Transgender communitiesMSM/Transgender psychosocialSyndemic factorsTransgender populations

Identifiers

PMID32123636
PMCPMC7031880
OpenAlexW3006189106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.